Clinical Trial Design & Analysis
Harness next-generation cloud-based study simulation for unique statistical insights supporting earlier decision-making and more successful clinical development.
Clinical Trial Design
& Analysis
& Analysis
Harness next-generation cloud-based study simulation for unique statistical insights supporting earlier decision-making and more successful clinical development.
Optimise your study for success
Don’t let the wrong design and analysis approach be the reason for study failure.
Accelerate development, reducing risks and costs, by optimising clinical studies with KerusCloud.
This uniquely powerful software simulates thousands of realistic clinical scenarios at a time, so every variable aspect of a study’s design can be fully optimised in silico. Fast and cost-effective, KerusCloud ensures that only the best design is used for a real trial.
With KerusCloud multiple key aspects of a clinical study can be optimised rapidly including:
- Target population
- Study Design
- Endpoints
- Analysis Strategy
- Success Criteria
KerusCloud addresses current development issues such as:
- Selecting the best development strategy
- Choosing between standard or complex innovative design trials such as adaptive platform trials (APTs), seamless studies, basket trials and umbrella trials
- Improving study success rates
- Identifying the best endpoint and patient subgroups
- Generating robust evidence packages for drug approval
- Supporting investment decisions
- Implementing Precision Medicine strategies
- Anonymising real-world data by generating realistic synthetic data
Accelerate development, reducing risks and costs, by optimising clinical studies with KerusCloud.
This uniquely powerful software simulates thousands of realistic clinical scenarios at a time, so every variable aspect of a study’s design can be fully optimised in silico. Fast and cost-effective, KerusCloud ensures that only the best design is used for a real trial.
With KerusCloud multiple key aspects of a clinical study can be optimised rapidly including:
- Target population
- Study Design
- Endpoints
- Analysis Strategy
- Success Criteria
KerusCloud addresses current development issues such as:
- Selecting the best development strategy
- Choosing between standard or complex innovative design trials such as adaptive platform trials (APTs), seamless studies, basket trials and umbrella trials
- Improving study success rates
- Identifying the best endpoint and patient subgroups
- Generating robust evidence packages for drug approval
- Supporting investment decisions
- Implementing Precision Medicine strategies
- Anonymising real-world data by generating realistic synthetic data
Transform Traditional Study Design with the New Data Driven KerusCloud Approach
KerusCloud facilitates informed decision-making by placing statistics at the heart of protocol development, addressing the growing complexity of modern clinical studies.
By incorporating KerusCloud into the clinical protocol development process information can be leveraged from available data earlier to inform key decisions. This ensures that real clinical studies are comprehensively de-risked and fully optimised in silico at the design stage using its rigorous evidence-based approach.
By incorporating KerusCloud into the clinical protocol development process information can be leveraged from available data earlier to inform key decisions. This ensures that real clinical studies are comprehensively de-risked and fully optimised in silico at the design stage using its rigorous evidence-based approach.
Optimising study design and analysis options with KerusCloud:
Accelerates development by identifying the right development path, first time.
Keruscloud has been seen to increase the probability of success of a single study by 41%.
Generates more evidence for the same costs.
De-risks investment through rapid evaluation and testing of assumptions.
Adds value to current drug pipelines and existing data.
For the best shot at success, choose KerusCloud.
Optimising study design and analysis options with KerusCloud:
Accelerates development by identifying the right development path, first time.
KerusCloud has been seen to increase study success by 41%.
Generates more evidence for the same costs.
De-risks investment through rapid evaluation and testing of assumptions.
Adds value to current drug pipelines and existing data.
For the best shot at success, choose KerusCloud.
Get in touch to find out more or book a demo.
Want to find out more? Get in touch.